Ignite Creation Date:
2025-12-25 @ 3:11 AM
Ignite Modification Date:
2026-02-27 @ 10:33 AM
Study NCT ID:
NCT03810105
Status:
TERMINATED
Last Update Posted:
2024-04-09
First Post:
2019-01-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Olaparib and Durvalumab in Prostate Cancer
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03-07
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-07-06
Completion Date Type:
ACTUAL
First Submit Date:
2019-01-17
First Submit QC Date:
None
Study First Post Date:
2019-01-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-03-11
Results First Submit QC Date:
None
Results First Post Date:
2024-04-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-11
Last Update Post Date:
2024-04-09
Last Update Post Date Type:
ACTUAL